2nd Quarter - Report
ARNOLD & PORTER KAYE SCHOLER LLP for RIGEL PHARMACEUTICALS INC.
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to federal funding for COVID-19 therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CJ MAHLER | — |
| BOBBY MCMILLIN New | Bobby McMillinGeneral Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-2013); Press Intern, Sen. Cha |
| EUGENIA PIERSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.